Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 24, 2015 10:56 PM ET

Pharmaceuticals

Company Overview of Collegium Pharmaceutical, Inc.

Executive Profile

Jeffrey M. Nugent

Chief Executive Officer, President, Director and Member of Finance Committee, BIOLASE, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 12 different industries.

See Board Relationships
67$451,172
As of Fiscal Year 2014

Background

Mr. Jeffrey M. Nugent, also known as Jeff, has been the Chief Executive Officer and President of BIOLASE, Inc. since September 2014 and served as its Acting Chief Executive Officer from June 2014 to September 2014. Mr. Nugent is the Founder and Senior Advisor of Precision Dermatology, Inc. He serves as the Chief Executive Officer of Precision Onset Dermatologics LLC. He served as an Executive Chairman, President and Chief Executive Officer of Ventus Medical Inc. He served ...

Corporate Headquarters

780 Dedham Street
Canton, Massachusetts 02021

United States

Phone: 781-713-3699
Fax: --

Board Members Memberships

Former Chairman
Former Director
Former Executive Chairman
Founder and Senior Advisor
2000-N/A
Former Chief Executive Officer, President and Director
2000-N/A
Former Chief Executive Officer, President and Director
2009-Present
Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
2014-Present
Chief Executive Officer, President, Director and Member of Finance Committee
2014-Present
Director, Member of Compensation Committee and Member of Audit Committee

Education

MBA
Loyola University of Chicago
BS
Saint Joseph's College of Indiana

Other Affiliations

Annual Compensation

Salary$150,000
Total Annual Compensation$150,000

Stocks Options

Restricted Stock Awards$75,000
All Other Compensation$1,172
Exercisable Options$88,534
Unexercisable Options$83,748
Total Number of Options$172,282

Total Compensation

Total Annual Cash Compensation$151,172
Total Short Term Compensation$150,000
Other Long Term Compensation$76,172
Total Calculated Compensation$451,172
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William C. Mills IIIChairman of the Board, Chief Executive Officer and Chairman of Strategy & Technology Committee
Stereotaxis Inc.
$662.3K
Kevin P. Connors Chief Executive Officer, President and Executive Director
Cutera, Inc.
$523.6K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Robert C.E. Kill Chairman, Chief Executive Officer and President
Cogentix Medical, Inc.
$589.2K
Daniel Goldberger Chief Executive Officer and Director
Bacterin International Holdings, Inc.
$500.2K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Collegium Pharmaceutical, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.